Baidu
map

青年和老年结肠癌患者发病原因有着基因差异

2016-01-23 QQduhp 译 MedSci原创

这项研究的结果在2016年胃肠道癌症研讨会上宣讲。科罗拉多大学医学院Christopher Lieu指出,青年和老年结直肠癌患者肿瘤样本有明显的遗传差异。 虽然美国整体结直肠癌发生率降低,但是50岁以上的成年人患结直肠癌的发病率上升10%左右。Lieu教授和同事们通过对近期的数据分析后也发现,年轻的肿瘤患者病情恶化更快,死亡的风险更高。 这项研究的目的是密切地观察任何可能解释青年及中老年人结直肠癌

这项研究的结果在2016年胃肠道癌症研讨会上宣讲的。科罗拉多大学医学院Christopher Lieu指出,青年和老年结直肠癌患者肿瘤样本有明显的遗传差异。 

虽然美国整体结直肠癌发生率降低,但是50岁以上的成年人患结直肠癌的发病率上升10%左右。

Lieu教授和同事们通过对近期的数据分析后也发现,年轻的肿瘤患者病情恶化更快,死亡的风险更高。 

这项研究的目的是密切地观察任何可能解释青年及中老年人结直肠癌的遗传原因差异及为何年轻人肿瘤死亡风险更高。 

Lieu教授和同事比较了青年(31岁)和老年(73岁)男性罹患9大肿瘤的数据,他们对肿瘤样本中的4500万个可疑基因进行了分析。他们发现,相比老年人的23个基因被修饰而言,青年肿瘤患者共有77个基因得以修饰。青年患者的许多修饰基因大多参与细胞增殖,且通常与癌症有关,比如ERBB2、NOTCH3、CAV1。老年患者的肿瘤相关修饰基因主要参与细胞分化与细胞增殖——例如CDX2、HMGB3、EPHB2。

研究人员试图将调查民众扩大化,同时采用临床药物测试使青年和老年结直肠癌肿瘤治疗个体化,并进一步延长肿瘤患者的生存时间,提高他们的生存质量。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2085270, encodeId=315520852e084, content=<a href='/topic/show?id=3a7541e37ea' target=_blank style='color:#2F92EE;'>#基因差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41737, encryptionId=3a7541e37ea, topicName=基因差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon Nov 14 19:50:00 CST 2016, time=2016-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61301, encodeId=283761301b9, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61302, encodeId=f534613020e, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61299, encodeId=1ea06129977, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61300, encodeId=88d76130030, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2085270, encodeId=315520852e084, content=<a href='/topic/show?id=3a7541e37ea' target=_blank style='color:#2F92EE;'>#基因差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41737, encryptionId=3a7541e37ea, topicName=基因差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon Nov 14 19:50:00 CST 2016, time=2016-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61301, encodeId=283761301b9, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61302, encodeId=f534613020e, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61299, encodeId=1ea06129977, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61300, encodeId=88d76130030, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=)]
    2016-01-27 doctording1

    是一篇不错的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2085270, encodeId=315520852e084, content=<a href='/topic/show?id=3a7541e37ea' target=_blank style='color:#2F92EE;'>#基因差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41737, encryptionId=3a7541e37ea, topicName=基因差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon Nov 14 19:50:00 CST 2016, time=2016-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61301, encodeId=283761301b9, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61302, encodeId=f534613020e, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61299, encodeId=1ea06129977, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61300, encodeId=88d76130030, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=)]
    2016-01-27 doctording1

    值得进一步关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2085270, encodeId=315520852e084, content=<a href='/topic/show?id=3a7541e37ea' target=_blank style='color:#2F92EE;'>#基因差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41737, encryptionId=3a7541e37ea, topicName=基因差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon Nov 14 19:50:00 CST 2016, time=2016-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61301, encodeId=283761301b9, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61302, encodeId=f534613020e, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61299, encodeId=1ea06129977, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61300, encodeId=88d76130030, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=)]
    2016-01-27 doctording1

    不错,赞一个

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2085270, encodeId=315520852e084, content=<a href='/topic/show?id=3a7541e37ea' target=_blank style='color:#2F92EE;'>#基因差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41737, encryptionId=3a7541e37ea, topicName=基因差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon Nov 14 19:50:00 CST 2016, time=2016-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61301, encodeId=283761301b9, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61302, encodeId=f534613020e, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:06:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61299, encodeId=1ea06129977, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61300, encodeId=88d76130030, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 20:05:00 CST 2016, time=2016-01-27, status=1, ipAttribution=)]
    2016-01-27 doctording1

    这篇文章有一定深度

    0

相关资讯

Oncogene:Sprouty2基因可促使结直肠肿瘤细胞转移

哥伦比亚密苏里大学医学院研究人员进行的研究表明,Sprouty2基因的探索及发现有助于探索治疗结直肠癌新方案。研究发表在Oncogene。约1/20的民众将患有结直肠癌,女性的患癌风险比男性稍低。来自美国癌症协会的数据显示,美国2015年有39610例新发直肠癌病例和93090例新发结肠癌病例,总计约49700名患者死亡。 胃肠科和肝外科的Sharad Khare博士认为,既往认为Sprouty2

Oncogene:抑癌基因Sprouty2双面功能,也可能促进结直肠癌转移

图片来源:medicalxpress.com 近日,来自美国密苏里大学医学院的研究人员通过研究发现,一种可以抑制多种癌症生长和扩散的基因或许可以促进某些结直肠癌的生长和扩散,相关研究刊登于国际杂志Oncogene上,该研究为后期开发治疗结直肠癌的新疗法提供了新的思路和希望。 文章中,研究人员Sharad Khare说道,这种基因名为Sprouty2,此前该基因被认为可以帮助抵御癌症转移或癌

Lancet:宣传方式对结直肠癌筛查的影响大有不同!

英国结直肠癌筛查项目因社会经济状态不同存在差异,研究者进行了一项研究,评估备选4种干预方案能否减少这种差异,改善筛查有益健康。该研究纳入了60-74岁所有具有筛查资格的人群。每组试验均是标准信息与标准信息基础上添加干预的比较:干预1(2012年11月),总结关键信息要点的补充传单;干预2(2012年3月),描述参与者故事的叙述传单;干预3(2013年6月),医师通过邀请函支持该项目;干预4(201

Am J Clin Nutr:红肉或加工肉不会影响结直肠癌患者的生存

诊断结直肠癌(CRC)后红肉和加工肉的摄入或摄入变化对预后的影响目前知之甚少。研究者对3122名诊断为CRC患者随访中位数4.8年,调查CRC患者基线红肉和加工肉摄入与生存结局的关系,以后诊断CRC5年内红肉和加工肉摄入变化与生存结局的关系。研究者通过标准的问卷在纳入研究时和随访第5年获取参与者相关资料,通过Cox比例风险回归模型探究两者间关系。研究数据显示,所有Ⅰ-Ⅲ期CRC患者,基线资料里每天

BMC Cancer:不想患结直肠癌?多吃含钙物质!

摄入高剂量的饮食钙被认为具有预防直肠癌的作用,研究者对日常饮食钙摄入非常低的韩国人进行了一项病例对照研究,探究饮食钙摄入和结直肠癌风险间的剂量反应关系。该研究纳入了2010年8月-2013年8月诊断为结直肠癌的患者,同时纳入对照组。通过半定量食物频度问卷调查采集参与者饮食钙摄入情况,并根据癌症位置将其分为结肠癌、远端结肠癌和直肠癌。使用二元和多分类回归分析模型评估饮食钙摄入量和结直肠癌风险间联系。

Cell Rep:科学家阐明治疗结直肠癌的新靶点

图片来源:www.oncology-central.com 近日,一项刊登在国际杂志Cell Reports上的研究论文中,来自迈阿密大学米勒医学院的研究人员通过对结直肠癌进行研究,报道了机体免疫反应对肿瘤产生反应的关键性研究发现,这项研究也首次详细地解释了干扰素基因刺激子(STING,stimulator of interferon genes)信号通路如何扮演重要的角色来改变机体对细胞转

Baidu
map
Baidu
map
Baidu
map